No abstract

MR imaging accurately depicts the compartmentlike distribution of signal intensity abnormalities in patients with ITBFS.

OBJECTIVE. The objectiveof our studywas to analyzeMR imagesof vascularleiomy oma of the extremity and to compare these images with histopathologic findings to determine if a correlation exists. CONCLUSION. T2-weightedMR imagesof vascular leiomyomaof anextremityshowedamass with mixed areas that were both hyper-and isointense to skeletal muscle and also revealed a hypointense rim; these images correlate with histopathologic findings of smooth muscle, vessels, fibrous tissue, an intravascular thrombus, and a fibrous capsule. Downloaded from www.ajronline.org by 18.236.120.13 on 05/12/18 from IP address 18.236.120.13.

Thoracolumbar junction, shorter distance from the treated vertebrae, and greater degree of height restoration of the cemented vertebrae may increase the fracture risk of vertebrae adjacent to cement vertebrae after vertebroplasty.

To evaluate the prognostic implication of ground-glass attenuation at high-resolution computed tomography (HRCT) in assessing response to treatment in fibrosing alveolitis, the authors correlated HRCT findings with the improvement in pulmonary function, as represented by the increase in percentage predicted values on pulmonary function tests after corticosteroid therapy. Nineteen patients underwent HRCT before treatment and pulmonary function testing before and after treatment. The HRCT scans were reviewed by two independent observers. Areas of ground-glass attenuation were quantified subjectively by using a 0%-100% scale with 10% increments. The extent of ground-glass attenuation at HRCT was significantly correlated with improvement in diffusing capacity for carbon monoxide (r = .67, P = .0019), forced vital capacity (r = .71, P = .0007), and forced expiratory volume in 1 second (r = .64, P = .0034) after steroid treatment. These results suggest that ground-glass attenuation at HRCT is a good predictor of response to treatment in fibrosing alveolitis.

Background/Aims: The role of serum myokine levels in sarcopenia and the outcome of hepatocellular carcinoma (HCC) patients are not clear. This study investigated the serum levels of myostatin, follistatin, and interleukin-6 (IL-6) in HCC patients and their association with sarcopenia and survival.Methods: Using prospectively collected pretreatment samples from 238 HCC patients in a hospital from 2012 to 2015, the serum levels of 3 myokines were determined and compared to 50 samples from age and sex-matched healthy controls. Sarcopenia was evaluated using the psoas muscle index (PMI) measured at the third lumbar level in the computed tomography, and clinical data were collected until 2017.Results: The median levels of the 3 myokines for the male and female HCC patients were as follow: myostatin (3,979.3 and 2,976.3 pg/mL), follistatin (2,118.5 and 2,174.6 pg/mL), and IL-6 (2.5 and 2.7 pg/mL), respectively. Those in the HCC patients were all significantly higher than in the healthy controls. In the HCC patient, the median PMI was 4.43 (males) and 2.17 cm²/m² (females) with a sarcopenic prevalence of 56.4%. The serum levels of myostatin, IL-6 and follistatin in the HCC patients showed a positive, negative, and no correlation with PMI, respectively. The serum follistatin level was an independent factor for poor survival in HCC patients.Conclusions: The serum levels of myostatin, follistatin, and IL-6 and their correlation with sarcopenia and survival were presented in HCC patients for the first time. The role of the serum follistatin level as a poor prognostic biomarker warrants further study.

MR imaging of bone abnormalities, extraarticular lesions, and associated abscesses provides useful information in the differentiation of tuberculous arthritis and pyogenic arthritis.

3 J. MAGN. RESON. IMAGING 2017;45:1534-1544.